Skip to main content

JPMORGAN CHASE & CO

Position in IMVT — Immunovant, Inc.

CIK 19617 NEW YORK, NY

Position in IMVT

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$2,406,546
+$376,355 QoQ
Shares Held
96,882
+21.3% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 25% Shared 0% None 75%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,063,537 across 407 Biotechnology names. IMVT ranks #135 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMVT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,406,546 96,882
2025-12-31 $2,030,191 79,866
2025-09-30 $1,214,318 75,330
2025-06-30 $7,652,208 478,263
2025-03-31 $11,154,966 652,719
2024-12-31 $28,568,180 1,153,338
2024-09-30 $6,507,605 228,257
2024-06-30 $6,780,653 256,843
2024-03-31 $7,917,015 245,033
2023-12-31 $19,842,806 470,990
2023-09-30 $16,450,420 428,508
2023-06-30 $8,394,395 442,509
2023-03-31 $961,495 61,992
2022-12-31 $894,848 50,414
2022-09-30 $910,699 163,208
2022-06-30 $2,547,405 653,181
2022-03-31 $2,543,315 461,582
2021-12-31 $1,287,047 151,062
2021-09-30 $3,117,909 358,793
2021-06-30 $323,831 30,637
2021-03-31 $405,153 25,259
2020-12-31 $964,216 20,875
2020-09-30 $605,935 17,219
2020-06-30 $391,472 16,077
2020-03-31 $45,263 2,908